Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
Favaloro EJ.
Am J Hematol. 2020 Jan;95(1):117-128. doi: 10.1002/ajh.25669. Epub 2019 Nov 20.
Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
Moore GW, Foxton E, Platton S, Yartey N, White D, MacDonald SG.
J Thromb Haemost. 2023 Dec;21(12):3539-3546. doi: 10.1016/j.jtha.2023.08.009. Epub 2023 Aug 18.
Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas.
Moore GW, Kumano O.
J Thromb Haemost. 2020 Feb;18(2):439-444. doi: 10.1111/jth.14669. Epub 2019 Nov 15.
Lupus anticoagulant.
Creagh MD, Greaves M.
Blood Rev. 1991 Sep;5(3):162-7. doi: 10.1016/0268-960x(91)90033-9.
Magnesium-dependent activated partial thromboplastin time assay-Simple method for lupus anticoagulant detection.
Tokutake T, Ieko M, Naito S, Yoshida M, Baba H, Kobayashi H, Ishida F.
Int J Lab Hematol. 2020 Feb;42(1):46-51. doi: 10.1111/ijlh.13134. Epub 2019 Dec 10.
Lupus anticoagulant testing.
Moffat K, Raby A, Crowther M.
Methods Mol Biol. 2013;992:97-108. doi: 10.1007/978-1-62703-339-8_7.
Antiphospholipid antibody testing.
Sciascia S, Montaruli B, Infantino M.
Med Clin (Barc). 2024 Aug;163 Suppl 1:S4-S9. doi: 10.1016/j.medcli.2024.06.002.
Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).
Moore GW.
Methods Mol Biol. 2023;2663:275-288. doi: 10.1007/978-1-0716-3175-1_17.
Rivaroxaban Therapy, False-Positive Lupus Anticoagulant Screening Results, and Confirmatory Assay Results.
Murer LM, Pirruccello SJ, Koepsell SA.
Lab Med. 2016 Nov;47(4):275-278. doi: 10.1093/labmed/lmw029. Epub 2016 Jul 29.
Lupus anticoagulant.
Jacobson DM.
Stroke. 1987 Sep-Oct;18(5):961-2. doi: 10.1161/01.str.18.5.961.
